Literature DB >> 20542667

Second-generation antipsychotics and constipation: a review of the literature.

M De Hert1, H Hudyana, L Dockx, C Bernagie, K Sweers, J Tack, S Leucht, J Peuskens.   

Abstract

Antipsychotics are the cornerstone in the management of psychotic disorders and schizophrenia. They are effective agents but also have a wide range of side effects. In the recent literature constipation as possible side effect has received little attention. A review of the literature concerning constipation associated with antipsychotics was performed. Overall constipation is a rarely studied or reported side effect of antipsychotic medication. Nevertheless constipation is a common side effect. Antipsychotic agents differ in their liability to induce constipation. Constipation can be severe and can lead to serious consequences such as paralytic ileus, bowel occlusion and death. Active screening, monitoring and treatment are recommended. Further research on incidence, prevalence, underlying mechanisms and preventive measures is required. Copyright Â
© 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20542667     DOI: 10.1016/j.eurpsy.2010.03.003

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  31 in total

Review 1.  Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

Authors:  Domenico De Berardis; Gabriella Rapini; Luigi Olivieri; Domenico Di Nicola; Carmine Tomasetti; Alessandro Valchera; Michele Fornaro; Fabio Di Fabio; Giampaolo Perna; Marco Di Nicola; Gianluca Serafini; Alessandro Carano; Maurizio Pompili; Federica Vellante; Laura Orsolini; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Ther Adv Drug Saf       Date:  2018-02-06

2.  Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.

Authors:  Christoph U Correll; Johan Detraux; Jan De Lepeleire; Marc De Hert
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

3.  A case report of clozapine-induced severe gastrointestinal hypomotility.

Authors:  Giang H Nguyen; Neil Brahmbhatt; Thomas W Heinrich
Journal:  Prim Care Companion CNS Disord       Date:  2014-11-20

Review 4.  Clozapine in primary care.

Authors:  Karl Winckel; Dan Siskind
Journal:  Aust Prescr       Date:  2017-12-04

Review 5.  The phenolic interactome and gut microbiota: opportunities and challenges in developing applications for schizophrenia and autism.

Authors:  George E Jaskiw; Mark E Obrenovich; Curtis J Donskey
Journal:  Psychopharmacology (Berl)       Date:  2019-06-13       Impact factor: 4.530

6.  Association of Rigid-Compulsive Behavior with Functional Constipation in Autism Spectrum Disorder.

Authors:  Sarah Marler; Bradley J Ferguson; Evon Batey Lee; Brittany Peters; Kent C Williams; Erin McDonnell; Eric A Macklin; Pat Levitt; Kara Gross Margolis; David Q Beversdorf; Jeremy Veenstra-VanderWeele
Journal:  J Autism Dev Disord       Date:  2017-06

Review 7.  Drug-induced gastrointestinal disorders.

Authors:  H L Philpott; S Nandurkar; J Lubel; P R Gibson
Journal:  Frontline Gastroenterol       Date:  2013-06-19

8.  Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.

Authors:  Marc DE Hert; Christoph U Correll; Julio Bobes; Marcelo Cetkovich-Bakmas; Dan Cohen; Itsuo Asai; Johan Detraux; Shiv Gautam; Hans-Jurgen Möller; David M Ndetei; John W Newcomer; Richard Uwakwe; Stefan Leucht
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

9.  Risk factors for ileus in patients with schizophrenia.

Authors:  Jimmi Nielsen; Jonathan M Meyer
Journal:  Schizophr Bull       Date:  2010-11-26       Impact factor: 9.306

10.  Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a randomized, placebo-controlled trial.

Authors:  Faith B Dickerson; Cassie Stallings; Andrea Origoni; Emily Katsafanas; Christina L G Savage; Lucy A B Schweinfurth; Joshana Goga; Sunil Khushalani; Robert H Yolken
Journal:  Prim Care Companion CNS Disord       Date:  2014-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.